nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—ABCB1—colon cancer	0.436	1	CbGaD
Paroxetine—CYP2B6—Irinotecan—colon cancer	0.0527	0.231	CbGbCtD
Paroxetine—CYP2C9—Capecitabine—colon cancer	0.045	0.198	CbGbCtD
Paroxetine—CYP2C8—Fluorouracil—colon cancer	0.0383	0.168	CbGbCtD
Paroxetine—ABCB1—Irinotecan—colon cancer	0.027	0.119	CbGbCtD
Paroxetine—CYP2C9—Fluorouracil—colon cancer	0.0267	0.117	CbGbCtD
Paroxetine—ABCB1—Vincristine—colon cancer	0.0236	0.104	CbGbCtD
Paroxetine—CHRM3—ureter—colon cancer	0.0144	0.196	CbGeAlD
Paroxetine—ABCB1—Methotrexate—colon cancer	0.0143	0.0628	CbGbCtD
Paroxetine—CHRM3—muscle of abdomen—colon cancer	0.0103	0.141	CbGeAlD
Paroxetine—HTR2A—myenteric nerve plexus—colon cancer	0.00734	0.1	CbGeAlD
Paroxetine—HTR2A—vein—colon cancer	0.00473	0.0646	CbGeAlD
Paroxetine—TACR1—smooth muscle tissue—colon cancer	0.00289	0.0394	CbGeAlD
Paroxetine—TACR1—renal system—colon cancer	0.00278	0.038	CbGeAlD
Paroxetine—TACR1—digestive system—colon cancer	0.00228	0.0311	CbGeAlD
Paroxetine—CHRM5—epithelium—colon cancer	0.0022	0.0301	CbGeAlD
Paroxetine—HTR2A—endothelium—colon cancer	0.00163	0.0222	CbGeAlD
Paroxetine—HTR2A—blood vessel—colon cancer	0.0015	0.0205	CbGeAlD
Paroxetine—TACR1—lymph node—colon cancer	0.0013	0.0178	CbGeAlD
Paroxetine—CHRM3—smooth muscle tissue—colon cancer	0.00119	0.0162	CbGeAlD
Paroxetine—CHRM3—renal system—colon cancer	0.00114	0.0156	CbGeAlD
Paroxetine—SLC6A4—digestive system—colon cancer	0.00105	0.0144	CbGeAlD
Paroxetine—ABCB1—blood vessel—colon cancer	0.000984	0.0134	CbGeAlD
Paroxetine—CHRM3—digestive system—colon cancer	0.000937	0.0128	CbGeAlD
Paroxetine—CYP2C8—renal system—colon cancer	0.000926	0.0127	CbGeAlD
Paroxetine—HTR2A—embryo—colon cancer	0.000896	0.0122	CbGeAlD
Paroxetine—CYP2B6—renal system—colon cancer	0.000831	0.0114	CbGeAlD
Paroxetine—HTR2A—epithelium—colon cancer	0.000731	0.00998	CbGeAlD
Paroxetine—HTR2A—smooth muscle tissue—colon cancer	0.000704	0.00962	CbGeAlD
Paroxetine—CYP2B6—lymphoid tissue—colon cancer	0.00069	0.00943	CbGeAlD
Paroxetine—CYP2B6—digestive system—colon cancer	0.000682	0.00931	CbGeAlD
Paroxetine—HTR2A—renal system—colon cancer	0.000678	0.00926	CbGeAlD
Paroxetine—CYP2C9—digestive system—colon cancer	0.000675	0.00922	CbGeAlD
Paroxetine—CYP2C8—vagina—colon cancer	0.000671	0.00917	CbGeAlD
Paroxetine—CYP2D6—renal system—colon cancer	0.000618	0.00844	CbGeAlD
Paroxetine—CYP2B6—vagina—colon cancer	0.000602	0.00822	CbGeAlD
Paroxetine—ABCB1—embryo—colon cancer	0.000587	0.00802	CbGeAlD
Paroxetine—CYP2C8—liver—colon cancer	0.000566	0.00773	CbGeAlD
Paroxetine—HTR2A—digestive system—colon cancer	0.000556	0.0076	CbGeAlD
Paroxetine—SLC6A2—lymph node—colon cancer	0.000528	0.00722	CbGeAlD
Paroxetine—CYP2B6—liver—colon cancer	0.000508	0.00694	CbGeAlD
Paroxetine—CYP2D6—digestive system—colon cancer	0.000506	0.00692	CbGeAlD
Paroxetine—CYP2C9—liver—colon cancer	0.000503	0.00687	CbGeAlD
Paroxetine—HTR2A—vagina—colon cancer	0.000491	0.00671	CbGeAlD
Paroxetine—ABCB1—epithelium—colon cancer	0.000479	0.00654	CbGeAlD
Paroxetine—ABCB1—renal system—colon cancer	0.000444	0.00607	CbGeAlD
Paroxetine—HTR2A—liver—colon cancer	0.000414	0.00566	CbGeAlD
Paroxetine—CYP2D6—liver—colon cancer	0.000377	0.00515	CbGeAlD
Paroxetine—ABCB1—lymphoid tissue—colon cancer	0.000369	0.00504	CbGeAlD
Paroxetine—ABCB1—digestive system—colon cancer	0.000364	0.00498	CbGeAlD
Paroxetine—ABCB1—bone marrow—colon cancer	0.000336	0.00459	CbGeAlD
Paroxetine—ABCB1—vagina—colon cancer	0.000322	0.0044	CbGeAlD
Paroxetine—ABCB1—liver—colon cancer	0.000271	0.00371	CbGeAlD
Paroxetine—Discomfort—Fluorouracil—colon cancer	0.000232	0.000881	CcSEcCtD
Paroxetine—Shock—Irinotecan—colon cancer	0.000231	0.000878	CcSEcCtD
Paroxetine—Nervous system disorder—Irinotecan—colon cancer	0.000231	0.000876	CcSEcCtD
Paroxetine—Agranulocytosis—Capecitabine—colon cancer	0.00023	0.000874	CcSEcCtD
Paroxetine—Thrombocytopenia—Irinotecan—colon cancer	0.00023	0.000874	CcSEcCtD
Paroxetine—Hyperhidrosis—Irinotecan—colon cancer	0.000227	0.000863	CcSEcCtD
Paroxetine—Confusional state—Fluorouracil—colon cancer	0.000227	0.000862	CcSEcCtD
Paroxetine—Mood swings—Methotrexate—colon cancer	0.000226	0.000857	CcSEcCtD
Paroxetine—Hypotension—Vincristine—colon cancer	0.000226	0.000857	CcSEcCtD
Paroxetine—Bradycardia—Capecitabine—colon cancer	0.000226	0.000856	CcSEcCtD
Paroxetine—Oedema—Fluorouracil—colon cancer	0.000225	0.000855	CcSEcCtD
Paroxetine—Anaphylactic shock—Fluorouracil—colon cancer	0.000225	0.000855	CcSEcCtD
Paroxetine—Ataxia—Methotrexate—colon cancer	0.000224	0.000851	CcSEcCtD
Paroxetine—Infection—Fluorouracil—colon cancer	0.000224	0.00085	CcSEcCtD
Paroxetine—Haemoglobin—Capecitabine—colon cancer	0.000223	0.000845	CcSEcCtD
Paroxetine—Rhinitis—Capecitabine—colon cancer	0.000222	0.000843	CcSEcCtD
Paroxetine—Haemorrhage—Capecitabine—colon cancer	0.000222	0.000841	CcSEcCtD
Paroxetine—Hepatitis—Capecitabine—colon cancer	0.000222	0.000841	CcSEcCtD
Paroxetine—Nervous system disorder—Fluorouracil—colon cancer	0.000221	0.000839	CcSEcCtD
Paroxetine—Thrombocytopenia—Fluorouracil—colon cancer	0.000221	0.000837	CcSEcCtD
Paroxetine—Hypoaesthesia—Capecitabine—colon cancer	0.000221	0.000837	CcSEcCtD
Paroxetine—Liver function test abnormal—Methotrexate—colon cancer	0.00022	0.000836	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00022	0.000835	CcSEcCtD
Paroxetine—Pharyngitis—Capecitabine—colon cancer	0.00022	0.000835	CcSEcCtD
Paroxetine—Tachycardia—Fluorouracil—colon cancer	0.00022	0.000835	CcSEcCtD
Paroxetine—Hypotension—Irinotecan—colon cancer	0.00022	0.000834	CcSEcCtD
Paroxetine—Insomnia—Vincristine—colon cancer	0.000218	0.000829	CcSEcCtD
Paroxetine—Oedema peripheral—Capecitabine—colon cancer	0.000218	0.000829	CcSEcCtD
Paroxetine—Connective tissue disorder—Capecitabine—colon cancer	0.000218	0.000827	CcSEcCtD
Paroxetine—Paraesthesia—Vincristine—colon cancer	0.000217	0.000823	CcSEcCtD
Paroxetine—Breast disorder—Methotrexate—colon cancer	0.000216	0.000818	CcSEcCtD
Paroxetine—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000215	0.000815	CcSEcCtD
Paroxetine—Visual impairment—Capecitabine—colon cancer	0.000214	0.000811	CcSEcCtD
Paroxetine—Insomnia—Irinotecan—colon cancer	0.000213	0.000808	CcSEcCtD
Paroxetine—Paraesthesia—Irinotecan—colon cancer	0.000211	0.000802	CcSEcCtD
Paroxetine—Hypotension—Fluorouracil—colon cancer	0.000211	0.000799	CcSEcCtD
Paroxetine—Decreased appetite—Vincristine—colon cancer	0.00021	0.000797	CcSEcCtD
Paroxetine—Dyspnoea—Irinotecan—colon cancer	0.00021	0.000796	CcSEcCtD
Paroxetine—Erythema multiforme—Capecitabine—colon cancer	0.00021	0.000795	CcSEcCtD
Paroxetine—Somnolence—Irinotecan—colon cancer	0.000209	0.000794	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Vincristine—colon cancer	0.000209	0.000791	CcSEcCtD
Paroxetine—Fatigue—Vincristine—colon cancer	0.000208	0.00079	CcSEcCtD
Paroxetine—ABCB1—lymph node—colon cancer	0.000208	0.00284	CbGeAlD
Paroxetine—Eye disorder—Capecitabine—colon cancer	0.000207	0.000786	CcSEcCtD
Paroxetine—Dyspepsia—Irinotecan—colon cancer	0.000207	0.000786	CcSEcCtD
Paroxetine—Tinnitus—Capecitabine—colon cancer	0.000207	0.000784	CcSEcCtD
Paroxetine—Pain—Vincristine—colon cancer	0.000207	0.000784	CcSEcCtD
Paroxetine—Constipation—Vincristine—colon cancer	0.000207	0.000784	CcSEcCtD
Paroxetine—Asthma—Methotrexate—colon cancer	0.000206	0.000782	CcSEcCtD
Paroxetine—Cardiac disorder—Capecitabine—colon cancer	0.000206	0.000781	CcSEcCtD
Paroxetine—Flushing—Capecitabine—colon cancer	0.000206	0.000781	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000205	0.000779	CcSEcCtD
Paroxetine—Decreased appetite—Irinotecan—colon cancer	0.000205	0.000776	CcSEcCtD
Paroxetine—Eosinophilia—Methotrexate—colon cancer	0.000204	0.000775	CcSEcCtD
Paroxetine—Insomnia—Fluorouracil—colon cancer	0.000204	0.000773	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000203	0.000771	CcSEcCtD
Paroxetine—Fatigue—Irinotecan—colon cancer	0.000203	0.00077	CcSEcCtD
Paroxetine—Paraesthesia—Fluorouracil—colon cancer	0.000202	0.000768	CcSEcCtD
Paroxetine—Pancreatitis—Methotrexate—colon cancer	0.000202	0.000767	CcSEcCtD
Paroxetine—Pain—Irinotecan—colon cancer	0.000201	0.000763	CcSEcCtD
Paroxetine—Constipation—Irinotecan—colon cancer	0.000201	0.000763	CcSEcCtD
Paroxetine—Angiopathy—Capecitabine—colon cancer	0.000201	0.000763	CcSEcCtD
Paroxetine—Dyspnoea—Fluorouracil—colon cancer	0.000201	0.000762	CcSEcCtD
Paroxetine—Somnolence—Fluorouracil—colon cancer	0.0002	0.00076	CcSEcCtD
Paroxetine—Immune system disorder—Capecitabine—colon cancer	0.0002	0.00076	CcSEcCtD
Paroxetine—Mediastinal disorder—Capecitabine—colon cancer	0.0002	0.000758	CcSEcCtD
Paroxetine—Chills—Capecitabine—colon cancer	0.000199	0.000755	CcSEcCtD
Paroxetine—Dyspepsia—Fluorouracil—colon cancer	0.000198	0.000753	CcSEcCtD
Paroxetine—Arrhythmia—Capecitabine—colon cancer	0.000198	0.000751	CcSEcCtD
Paroxetine—Gastrointestinal pain—Vincristine—colon cancer	0.000198	0.00075	CcSEcCtD
Paroxetine—Decreased appetite—Fluorouracil—colon cancer	0.000196	0.000743	CcSEcCtD
Paroxetine—Alopecia—Capecitabine—colon cancer	0.000196	0.000743	CcSEcCtD
Paroxetine—Pancytopenia—Methotrexate—colon cancer	0.000196	0.000743	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000195	0.000738	CcSEcCtD
Paroxetine—Mental disorder—Capecitabine—colon cancer	0.000194	0.000737	CcSEcCtD
Paroxetine—Feeling abnormal—Irinotecan—colon cancer	0.000194	0.000736	CcSEcCtD
Paroxetine—Malnutrition—Capecitabine—colon cancer	0.000193	0.000732	CcSEcCtD
Paroxetine—Erythema—Capecitabine—colon cancer	0.000193	0.000732	CcSEcCtD
Paroxetine—Dysuria—Methotrexate—colon cancer	0.000193	0.000731	CcSEcCtD
Paroxetine—Pain—Fluorouracil—colon cancer	0.000193	0.000731	CcSEcCtD
Paroxetine—Gastrointestinal pain—Irinotecan—colon cancer	0.000192	0.00073	CcSEcCtD
Paroxetine—Abdominal pain—Vincristine—colon cancer	0.000191	0.000725	CcSEcCtD
Paroxetine—Body temperature increased—Vincristine—colon cancer	0.000191	0.000725	CcSEcCtD
Paroxetine—Flatulence—Capecitabine—colon cancer	0.00019	0.000721	CcSEcCtD
Paroxetine—Erectile dysfunction—Methotrexate—colon cancer	0.00019	0.00072	CcSEcCtD
Paroxetine—Dysgeusia—Capecitabine—colon cancer	0.000189	0.000717	CcSEcCtD
Paroxetine—Photosensitivity reaction—Methotrexate—colon cancer	0.000188	0.000714	CcSEcCtD
Paroxetine—Back pain—Capecitabine—colon cancer	0.000187	0.000708	CcSEcCtD
Paroxetine—Body temperature increased—Irinotecan—colon cancer	0.000186	0.000706	CcSEcCtD
Paroxetine—Abdominal pain—Irinotecan—colon cancer	0.000186	0.000706	CcSEcCtD
Paroxetine—Feeling abnormal—Fluorouracil—colon cancer	0.000186	0.000705	CcSEcCtD
Paroxetine—Muscle spasms—Capecitabine—colon cancer	0.000185	0.000704	CcSEcCtD
Paroxetine—Pneumonia—Methotrexate—colon cancer	0.000185	0.000702	CcSEcCtD
Paroxetine—Drowsiness—Methotrexate—colon cancer	0.000184	0.000697	CcSEcCtD
Paroxetine—Depression—Methotrexate—colon cancer	0.000183	0.000695	CcSEcCtD
Paroxetine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000182	0.000691	CcSEcCtD
Paroxetine—Vision blurred—Capecitabine—colon cancer	0.000182	0.00069	CcSEcCtD
Paroxetine—Tremor—Capecitabine—colon cancer	0.000181	0.000686	CcSEcCtD
Paroxetine—Stomatitis—Methotrexate—colon cancer	0.000179	0.00068	CcSEcCtD
Paroxetine—Ill-defined disorder—Capecitabine—colon cancer	0.000179	0.000679	CcSEcCtD
Paroxetine—Urticaria—Fluorouracil—colon cancer	0.000179	0.000679	CcSEcCtD
Paroxetine—Conjunctivitis—Methotrexate—colon cancer	0.000179	0.000678	CcSEcCtD
Paroxetine—Anaemia—Capecitabine—colon cancer	0.000178	0.000677	CcSEcCtD
Paroxetine—Body temperature increased—Fluorouracil—colon cancer	0.000178	0.000676	CcSEcCtD
Paroxetine—Hypersensitivity—Vincristine—colon cancer	0.000178	0.000675	CcSEcCtD
Paroxetine—Sweating—Methotrexate—colon cancer	0.000176	0.000669	CcSEcCtD
Paroxetine—Haematuria—Methotrexate—colon cancer	0.000175	0.000665	CcSEcCtD
Paroxetine—Malaise—Capecitabine—colon cancer	0.000174	0.00066	CcSEcCtD
Paroxetine—Hepatobiliary disease—Methotrexate—colon cancer	0.000174	0.00066	CcSEcCtD
Paroxetine—Epistaxis—Methotrexate—colon cancer	0.000173	0.000658	CcSEcCtD
Paroxetine—Vertigo—Capecitabine—colon cancer	0.000173	0.000658	CcSEcCtD
Paroxetine—Hypersensitivity—Irinotecan—colon cancer	0.000173	0.000658	CcSEcCtD
Paroxetine—Asthenia—Vincristine—colon cancer	0.000173	0.000658	CcSEcCtD
Paroxetine—Syncope—Capecitabine—colon cancer	0.000173	0.000657	CcSEcCtD
Paroxetine—Leukopenia—Capecitabine—colon cancer	0.000173	0.000655	CcSEcCtD
Paroxetine—Agranulocytosis—Methotrexate—colon cancer	0.000172	0.000651	CcSEcCtD
Paroxetine—Palpitations—Capecitabine—colon cancer	0.00017	0.000647	CcSEcCtD
Paroxetine—Loss of consciousness—Capecitabine—colon cancer	0.00017	0.000644	CcSEcCtD
Paroxetine—Asthenia—Irinotecan—colon cancer	0.000169	0.000641	CcSEcCtD
Paroxetine—Cough—Capecitabine—colon cancer	0.000168	0.000639	CcSEcCtD
Paroxetine—Hypertension—Capecitabine—colon cancer	0.000167	0.000632	CcSEcCtD
Paroxetine—Hypersensitivity—Fluorouracil—colon cancer	0.000166	0.00063	CcSEcCtD
Paroxetine—Haemoglobin—Methotrexate—colon cancer	0.000166	0.000629	CcSEcCtD
Paroxetine—Diarrhoea—Vincristine—colon cancer	0.000165	0.000627	CcSEcCtD
Paroxetine—Haemorrhage—Methotrexate—colon cancer	0.000165	0.000626	CcSEcCtD
Paroxetine—Hepatitis—Methotrexate—colon cancer	0.000165	0.000626	CcSEcCtD
Paroxetine—Chest pain—Capecitabine—colon cancer	0.000164	0.000623	CcSEcCtD
Paroxetine—Myalgia—Capecitabine—colon cancer	0.000164	0.000623	CcSEcCtD
Paroxetine—Arthralgia—Capecitabine—colon cancer	0.000164	0.000623	CcSEcCtD
Paroxetine—Pharyngitis—Methotrexate—colon cancer	0.000164	0.000621	CcSEcCtD
Paroxetine—Anxiety—Capecitabine—colon cancer	0.000164	0.000621	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000163	0.000619	CcSEcCtD
Paroxetine—Discomfort—Capecitabine—colon cancer	0.000162	0.000616	CcSEcCtD
Paroxetine—Diarrhoea—Irinotecan—colon cancer	0.000161	0.000611	CcSEcCtD
Paroxetine—Dry mouth—Capecitabine—colon cancer	0.000161	0.00061	CcSEcCtD
Paroxetine—Dizziness—Vincristine—colon cancer	0.00016	0.000606	CcSEcCtD
Paroxetine—Pruritus—Fluorouracil—colon cancer	0.000159	0.000605	CcSEcCtD
Paroxetine—Visual impairment—Methotrexate—colon cancer	0.000159	0.000603	CcSEcCtD
Paroxetine—Confusional state—Capecitabine—colon cancer	0.000159	0.000603	CcSEcCtD
Paroxetine—Oedema—Capecitabine—colon cancer	0.000157	0.000598	CcSEcCtD
Paroxetine—Infection—Capecitabine—colon cancer	0.000156	0.000594	CcSEcCtD
Paroxetine—Erythema multiforme—Methotrexate—colon cancer	0.000156	0.000592	CcSEcCtD
Paroxetine—Dizziness—Irinotecan—colon cancer	0.000156	0.00059	CcSEcCtD
Paroxetine—Shock—Capecitabine—colon cancer	0.000155	0.000588	CcSEcCtD
Paroxetine—Nervous system disorder—Capecitabine—colon cancer	0.000154	0.000586	CcSEcCtD
Paroxetine—Eye disorder—Methotrexate—colon cancer	0.000154	0.000585	CcSEcCtD
Paroxetine—Diarrhoea—Fluorouracil—colon cancer	0.000154	0.000585	CcSEcCtD
Paroxetine—Thrombocytopenia—Capecitabine—colon cancer	0.000154	0.000585	CcSEcCtD
Paroxetine—Tinnitus—Methotrexate—colon cancer	0.000154	0.000584	CcSEcCtD
Paroxetine—Tachycardia—Capecitabine—colon cancer	0.000154	0.000583	CcSEcCtD
Paroxetine—Vomiting—Vincristine—colon cancer	0.000154	0.000583	CcSEcCtD
Paroxetine—Cardiac disorder—Methotrexate—colon cancer	0.000153	0.000581	CcSEcCtD
Paroxetine—Skin disorder—Capecitabine—colon cancer	0.000153	0.00058	CcSEcCtD
Paroxetine—Rash—Vincristine—colon cancer	0.000152	0.000578	CcSEcCtD
Paroxetine—Hyperhidrosis—Capecitabine—colon cancer	0.000152	0.000578	CcSEcCtD
Paroxetine—Dermatitis—Vincristine—colon cancer	0.000152	0.000578	CcSEcCtD
Paroxetine—Headache—Vincristine—colon cancer	0.000151	0.000574	CcSEcCtD
Paroxetine—Angiopathy—Methotrexate—colon cancer	0.00015	0.000568	CcSEcCtD
Paroxetine—Vomiting—Irinotecan—colon cancer	0.00015	0.000568	CcSEcCtD
Paroxetine—Immune system disorder—Methotrexate—colon cancer	0.000149	0.000566	CcSEcCtD
Paroxetine—Dizziness—Fluorouracil—colon cancer	0.000149	0.000565	CcSEcCtD
Paroxetine—Mediastinal disorder—Methotrexate—colon cancer	0.000149	0.000564	CcSEcCtD
Paroxetine—Rash—Irinotecan—colon cancer	0.000148	0.000563	CcSEcCtD
Paroxetine—Dermatitis—Irinotecan—colon cancer	0.000148	0.000562	CcSEcCtD
Paroxetine—Chills—Methotrexate—colon cancer	0.000148	0.000562	CcSEcCtD
Paroxetine—Headache—Irinotecan—colon cancer	0.000147	0.000559	CcSEcCtD
Paroxetine—Hypotension—Capecitabine—colon cancer	0.000147	0.000558	CcSEcCtD
Paroxetine—Alopecia—Methotrexate—colon cancer	0.000146	0.000553	CcSEcCtD
Paroxetine—Mental disorder—Methotrexate—colon cancer	0.000145	0.000549	CcSEcCtD
Paroxetine—Erythema—Methotrexate—colon cancer	0.000144	0.000545	CcSEcCtD
Paroxetine—Malnutrition—Methotrexate—colon cancer	0.000144	0.000545	CcSEcCtD
Paroxetine—Nausea—Vincristine—colon cancer	0.000143	0.000545	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000143	0.000544	CcSEcCtD
Paroxetine—Vomiting—Fluorouracil—colon cancer	0.000143	0.000544	CcSEcCtD
Paroxetine—Insomnia—Capecitabine—colon cancer	0.000142	0.00054	CcSEcCtD
Paroxetine—Rash—Fluorouracil—colon cancer	0.000142	0.000539	CcSEcCtD
Paroxetine—Dermatitis—Fluorouracil—colon cancer	0.000142	0.000539	CcSEcCtD
Paroxetine—Paraesthesia—Capecitabine—colon cancer	0.000141	0.000537	CcSEcCtD
Paroxetine—Headache—Fluorouracil—colon cancer	0.000141	0.000536	CcSEcCtD
Paroxetine—Dysgeusia—Methotrexate—colon cancer	0.000141	0.000534	CcSEcCtD
Paroxetine—Dyspnoea—Capecitabine—colon cancer	0.00014	0.000533	CcSEcCtD
Paroxetine—Nausea—Irinotecan—colon cancer	0.00014	0.00053	CcSEcCtD
Paroxetine—Back pain—Methotrexate—colon cancer	0.000139	0.000527	CcSEcCtD
Paroxetine—Dyspepsia—Capecitabine—colon cancer	0.000139	0.000526	CcSEcCtD
Paroxetine—Decreased appetite—Capecitabine—colon cancer	0.000137	0.000519	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000136	0.000516	CcSEcCtD
Paroxetine—Fatigue—Capecitabine—colon cancer	0.000136	0.000515	CcSEcCtD
Paroxetine—Vision blurred—Methotrexate—colon cancer	0.000135	0.000514	CcSEcCtD
Paroxetine—Pain—Capecitabine—colon cancer	0.000135	0.000511	CcSEcCtD
Paroxetine—Constipation—Capecitabine—colon cancer	0.000135	0.000511	CcSEcCtD
Paroxetine—Nausea—Fluorouracil—colon cancer	0.000134	0.000508	CcSEcCtD
Paroxetine—Ill-defined disorder—Methotrexate—colon cancer	0.000133	0.000506	CcSEcCtD
Paroxetine—Anaemia—Methotrexate—colon cancer	0.000133	0.000504	CcSEcCtD
Paroxetine—Feeling abnormal—Capecitabine—colon cancer	0.00013	0.000492	CcSEcCtD
Paroxetine—Malaise—Methotrexate—colon cancer	0.00013	0.000492	CcSEcCtD
Paroxetine—Vertigo—Methotrexate—colon cancer	0.000129	0.00049	CcSEcCtD
Paroxetine—Gastrointestinal pain—Capecitabine—colon cancer	0.000129	0.000489	CcSEcCtD
Paroxetine—Leukopenia—Methotrexate—colon cancer	0.000129	0.000488	CcSEcCtD
Paroxetine—Cough—Methotrexate—colon cancer	0.000125	0.000476	CcSEcCtD
Paroxetine—Urticaria—Capecitabine—colon cancer	0.000125	0.000475	CcSEcCtD
Paroxetine—Body temperature increased—Capecitabine—colon cancer	0.000124	0.000472	CcSEcCtD
Paroxetine—Abdominal pain—Capecitabine—colon cancer	0.000124	0.000472	CcSEcCtD
Paroxetine—Convulsion—Methotrexate—colon cancer	0.000124	0.000472	CcSEcCtD
Paroxetine—Arthralgia—Methotrexate—colon cancer	0.000122	0.000464	CcSEcCtD
Paroxetine—Chest pain—Methotrexate—colon cancer	0.000122	0.000464	CcSEcCtD
Paroxetine—Myalgia—Methotrexate—colon cancer	0.000122	0.000464	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000121	0.000461	CcSEcCtD
Paroxetine—Discomfort—Methotrexate—colon cancer	0.000121	0.000458	CcSEcCtD
Paroxetine—Confusional state—Methotrexate—colon cancer	0.000118	0.000449	CcSEcCtD
Paroxetine—Anaphylactic shock—Methotrexate—colon cancer	0.000117	0.000445	CcSEcCtD
Paroxetine—Infection—Methotrexate—colon cancer	0.000116	0.000442	CcSEcCtD
Paroxetine—Hypersensitivity—Capecitabine—colon cancer	0.000116	0.00044	CcSEcCtD
Paroxetine—Nervous system disorder—Methotrexate—colon cancer	0.000115	0.000436	CcSEcCtD
Paroxetine—Thrombocytopenia—Methotrexate—colon cancer	0.000115	0.000436	CcSEcCtD
Paroxetine—Skin disorder—Methotrexate—colon cancer	0.000114	0.000432	CcSEcCtD
Paroxetine—Hyperhidrosis—Methotrexate—colon cancer	0.000113	0.00043	CcSEcCtD
Paroxetine—Asthenia—Capecitabine—colon cancer	0.000113	0.000429	CcSEcCtD
Paroxetine—Pruritus—Capecitabine—colon cancer	0.000111	0.000423	CcSEcCtD
Paroxetine—Hypotension—Methotrexate—colon cancer	0.00011	0.000416	CcSEcCtD
Paroxetine—Diarrhoea—Capecitabine—colon cancer	0.000108	0.000409	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000107	0.000405	CcSEcCtD
Paroxetine—Insomnia—Methotrexate—colon cancer	0.000106	0.000402	CcSEcCtD
Paroxetine—Paraesthesia—Methotrexate—colon cancer	0.000105	0.000399	CcSEcCtD
Paroxetine—Dyspnoea—Methotrexate—colon cancer	0.000105	0.000397	CcSEcCtD
Paroxetine—Somnolence—Methotrexate—colon cancer	0.000104	0.000395	CcSEcCtD
Paroxetine—Dizziness—Capecitabine—colon cancer	0.000104	0.000395	CcSEcCtD
Paroxetine—Dyspepsia—Methotrexate—colon cancer	0.000103	0.000392	CcSEcCtD
Paroxetine—Decreased appetite—Methotrexate—colon cancer	0.000102	0.000387	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000101	0.000384	CcSEcCtD
Paroxetine—Fatigue—Methotrexate—colon cancer	0.000101	0.000384	CcSEcCtD
Paroxetine—Pain—Methotrexate—colon cancer	0.0001	0.00038	CcSEcCtD
Paroxetine—Vomiting—Capecitabine—colon cancer	0.0001	0.00038	CcSEcCtD
Paroxetine—Rash—Capecitabine—colon cancer	9.93e-05	0.000377	CcSEcCtD
Paroxetine—Dermatitis—Capecitabine—colon cancer	9.92e-05	0.000376	CcSEcCtD
Paroxetine—Headache—Capecitabine—colon cancer	9.86e-05	0.000374	CcSEcCtD
Paroxetine—Feeling abnormal—Methotrexate—colon cancer	9.66e-05	0.000367	CcSEcCtD
Paroxetine—Gastrointestinal pain—Methotrexate—colon cancer	9.58e-05	0.000364	CcSEcCtD
Paroxetine—Nausea—Capecitabine—colon cancer	9.35e-05	0.000355	CcSEcCtD
Paroxetine—Urticaria—Methotrexate—colon cancer	9.31e-05	0.000353	CcSEcCtD
Paroxetine—Body temperature increased—Methotrexate—colon cancer	9.27e-05	0.000352	CcSEcCtD
Paroxetine—Abdominal pain—Methotrexate—colon cancer	9.27e-05	0.000352	CcSEcCtD
Paroxetine—Hypersensitivity—Methotrexate—colon cancer	8.64e-05	0.000328	CcSEcCtD
Paroxetine—Asthenia—Methotrexate—colon cancer	8.41e-05	0.000319	CcSEcCtD
Paroxetine—Pruritus—Methotrexate—colon cancer	8.29e-05	0.000315	CcSEcCtD
Paroxetine—Diarrhoea—Methotrexate—colon cancer	8.02e-05	0.000304	CcSEcCtD
Paroxetine—Dizziness—Methotrexate—colon cancer	7.75e-05	0.000294	CcSEcCtD
Paroxetine—Vomiting—Methotrexate—colon cancer	7.45e-05	0.000283	CcSEcCtD
Paroxetine—Rash—Methotrexate—colon cancer	7.39e-05	0.00028	CcSEcCtD
Paroxetine—Dermatitis—Methotrexate—colon cancer	7.38e-05	0.00028	CcSEcCtD
Paroxetine—Headache—Methotrexate—colon cancer	7.34e-05	0.000279	CcSEcCtD
Paroxetine—Nausea—Methotrexate—colon cancer	6.96e-05	0.000264	CcSEcCtD
